FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
8 letters match. Newest first.
-
DrugsAytu Biopharma
FDA says Aytu Biopharma’s sponsored links for ADHD drug Cotempla XR-ODT are false or misleading and misbrand it.
High risk -
DrugsAytu Biopharma
FDA warned Aytu Biopharma that sponsored links for ADHD drug Adzenys XR-ODT are false or misleading because they omit risk information.
High risk -
DrugsEli Lilly and Company
FDA says Eli Lilly’s Oprah-linked video for Zepbound and Mounjaro misled on serious risks.
High risk -
DrugsEli Lilly and Company
FDA says Eli Lilly's Zepbound online video omitted risk and limitations information and was not submitted to FDA.
High risk -
DrugsEli Lilly and Company
FDA says Eli Lilly's sponsored Zepbound video omitted risk and use information, misbranding the drug.
Low -
DrugsSprout Pharmaceuticals, Inc.
FDA warned Sprout Pharmaceuticals that a CEO Instagram post for Addyi omitted risks and indication limits.
High risk -
DrugsSarfez Pharmaceuticals, Inc.
FDA says Sarfez made false or misleading efficacy and risk claims for Soaanz (torsemide) in webpages, pamphlet, and exhibit panel.
High risk -
DrugsCooperSurgical, Inc.
FDA says CooperSurgical’s Paragard video omitted all risk information, making the birth-control promotion misleading and misbranded.
Low